256 related articles for article (PubMed ID: 11326297)
1. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.
Mirnics K; Middleton FA; Stanwood GD; Lewis DA; Levitt P
Mol Psychiatry; 2001 May; 6(3):293-301. PubMed ID: 11326297
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia.
Stuart Gibbons A; Scarr E; McOmish CE; Hannan AJ; Thomas EA; Dean B
Aust N Z J Psychiatry; 2008 Aug; 42(8):740-5. PubMed ID: 18622782
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia.
Pongrac JL; Middleton FA; Peng L; Lewis DA; Levitt P; Mirnics K
Biol Psychiatry; 2004 Dec; 56(12):943-50. PubMed ID: 15601604
[TBL] [Abstract][Full Text] [Related]
4. Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients.
Ding L; Hegde AN
Biol Psychiatry; 2009 Mar; 65(6):541-5. PubMed ID: 19041089
[TBL] [Abstract][Full Text] [Related]
5. Regional alterations in RGS4 protein in schizophrenia.
Erdely HA; Tamminga CA; Roberts RC; Vogel MW
Synapse; 2006 Jun; 59(8):472-9. PubMed ID: 16565965
[TBL] [Abstract][Full Text] [Related]
6. Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain.
Ding L; Mychaleckyj JC; Hegde AN
Gene; 2007 Oct; 401(1-2):46-60. PubMed ID: 17707117
[TBL] [Abstract][Full Text] [Related]
7. RGS4 modulates serotonin signaling in prefrontal cortex and links to serotonin dysfunction in a rat model of schizophrenia.
Gu Z; Jiang Q; Yan Z
Mol Pharmacol; 2007 Apr; 71(4):1030-9. PubMed ID: 17220354
[TBL] [Abstract][Full Text] [Related]
8. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Huang CH; Tsai GE
J Clin Psychopharmacol; 2008 Feb; 28(1):64-8. PubMed ID: 18204343
[TBL] [Abstract][Full Text] [Related]
9. Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts.
Stanwood GD; Parlaman JP; Levitt P
Eur J Neurosci; 2006 Aug; 24(3):806-18. PubMed ID: 16930410
[TBL] [Abstract][Full Text] [Related]
10. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
Lipska BK; Mitkus S; Caruso M; Hyde TM; Chen J; Vakkalanka R; Straub RE; Weinberger DR; Kleinman JE
Hum Mol Genet; 2006 Sep; 15(18):2804-12. PubMed ID: 16905560
[TBL] [Abstract][Full Text] [Related]
11. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
[TBL] [Abstract][Full Text] [Related]
12. Rgs4 mRNA expression is decreased in the brain of Fmr1 knockout mouse.
Tervonen T; Akerman K; Oostra BA; Castrén M
Brain Res Mol Brain Res; 2005 Jan; 133(1):162-5. PubMed ID: 15661377
[TBL] [Abstract][Full Text] [Related]
13. Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis.
Li D; He L
Eur J Hum Genet; 2006 Oct; 14(10):1130-5. PubMed ID: 16791139
[TBL] [Abstract][Full Text] [Related]
14. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
Bernstein HG; Ernst T; Lendeckel U; Bukowska A; Ansorge S; Stauch R; Have ST; Steiner J; Dobrowolny H; Bogerts B
J Psychiatr Res; 2009 Sep; 43(13):1095-105. PubMed ID: 19394958
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression.
Sugai T; Kawamura M; Iritani S; Araki K; Makifuchi T; Imai C; Nakamura R; Kakita A; Takahashi H; Nawa H
Ann N Y Acad Sci; 2004 Oct; 1025():84-91. PubMed ID: 15542704
[TBL] [Abstract][Full Text] [Related]
16. Regional expression of RGS4 mRNA in human brain.
Erdely HA; Lahti RA; Lopez MB; Myers CS; Roberts RC; Tamminga CA; Vogel MW
Eur J Neurosci; 2004 Jun; 19(11):3125-8. PubMed ID: 15182322
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity.
Ghavami A; Hunt RA; Olsen MA; Zhang J; Smith DL; Kalgaonkar S; Rahman Z; Young KH
Cell Signal; 2004 Jun; 16(6):711-21. PubMed ID: 15093612
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia.
Hill JJ; Hashimoto T; Lewis DA
Mol Psychiatry; 2006 Jun; 11(6):557-66. PubMed ID: 16402129
[TBL] [Abstract][Full Text] [Related]
19. Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain.
Rivero G; Gabilondo AM; García-Sevilla JA; La Harpe R; Morentín B; Javier Meana J
Neurochem Int; 2010 Dec; 57(7):722-9. PubMed ID: 20816714
[TBL] [Abstract][Full Text] [Related]
20. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.
Bodenstein J; Sunahara RK; Neubig RR
Mol Pharmacol; 2007 Apr; 71(4):1040-50. PubMed ID: 17220356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
